medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2015, Number 2

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2015; 31 (2)

Cytomegalovirus infection in HIV/ aids patients

Valdés CF, Fonseca GC, Capó PV, Bosch GL, Menéndez VA, Rivera KC, Serrano MJ

Language: Spanish
References: 49
Page: 113-126
PDF size: 114.58 Kb.


ABSTRACT

The cytomegalovirus (CMV) is considered a common opportunist microorganism among individuals with human immunodeficiency virus (HIV), the causal agent of the acquired immunodeficiency syndrome (Aids). The main consequence of the persistent transduction of HIV is the gradual reduction of the number of T cells CD4+, which eventually causes loss of immunologic competition. This human virus belongs to the family of herpes virus and frequently produces diseases mainly in different organs when the T CD4+ count is very low.


REFERENCES

  1. Botet F, Figueras Aloy J, Alvarez E, de Alba C, Dorronsolo I, Echaniz Urcelay I, et al. Universal cytomegalovirus infection screening in premature newborns less than 1500 g. An Pediatr (Barc). 2014 Oct;81(4):256.e1-4. doi: 10.1016/j.anpedi.2014.01.011.

  2. Akgün K, Huang L, Morris A, Justice A, Pisani M, Crothers K. Critical Ilness in HIV-Infected Patients in the era of combination antiretroviral therapy. Proc Am Thorac Soc. 2011 Jun;8(3):301-7. doi: 10.1513/pats.201009-060WR.

  3. Alp MN, Baykam N, Kural G. Immune recovery uveitis associated with highly active antiretroviral therapy in a patient with CMV retinitis and AIDS despite a low CD4+ T cell count: case report and a review of the literature. Int Ophthalmol. 2009 Apr;30(2):183-9.

  4. Alarcón R, Arredondo MR, Samaniego S, Taboada A, Benítez G. Infección por citomegalovirus en pacientes con SIDA. Rev Inst Med Trop. 2009 Dic.;4(2):7-13.

  5. Plotkin S. Vaccination against cytomegalovirus, the changeling demon. Pediatr Infect Dis J. 1999 Apr;18(4):313-25; quiz 326.

  6. Bodaghi B, Del Monte PD, Picard L, Bessia C, Michelson S. Human cytomegalovirus protein pp65 (ppUL83) plays a role in inhibition of host cell proteins synthesis. Scand J Infect Dis Suppl. 1995 99:41-2.

  7. Gamez SS, Ruiz MP, Navarro Mari JM. Infection by human cytomegalovirus. Enferm Infecc Microbiol Clin. 2014 Feb;32 Suppl 1:15-22.

  8. Bronke C, Palmer N, Jansen C. Dynamics of cytomegalovirus (CMV)-especific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease. J Infect Dis. 2005;191:873-80.

  9. Jaber S, Chanques G, Borry J. Cytomegalovirus infection in critically ill patients: associated factors and consequences. Chest. 2005;127:233-41.

  10. Deayton J, Sabin C, Jonson M, Emery V, Wilson P, Griffiths P. Importance of cytomegalovirus viremia in risk of disease progresion and death in HIV-infected patients receiving higgly active antiretroviral therapy. Lancet. 2004;363:2116-21.

  11. Xiao J, Gao G, Li Y, Zhang W, Tian Y, Huang Y, et al. Spectrums of opportunistic infections and malignancies in HIV-infected patients in tertiary care hospital, China. PLoS ONE. 2013;8(10):e75915.

  12. Murdoch DM, Venter WD, Feldman C, Van Rie A. Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study. AIDS. 2008 Mar 12;22(5):601-10.

  13. Das R, Sarkar S, Besra M. Bullous disorders as a manifestation of immune reconstitution inflammatory syndrome: A series of three cases. Indian J Sex Transm Dis. 2013 Jul;34(2):126-8.

  14. Barber DL, Andrade BB, Sereti I, Sher A. Immune reconstitution inflammatory syndrome: the trouble with immunity when you had none. Nat Rev Microbiol. 2012 Feb;10(2):150-6.

  15. Hibiya K, Tateyama M, Teruya H, Nakamura H, Tasato D, Kazumi Y, et al. Immunopathological characteristics of immune reconstitution inflammatory syndrome caused by Mycobacterium parascrofulaceum infection in a patient with AIDS. Pathol Res Pract. 2011 Apr 15;207(4):262-70.

  16. Von Both U, Laffer R, Grube C, Bossart W, Gaspert A, Günthard HF. Acute cytomegalovirus colitis presenting during primary HIV infection: an unusual case of an immune reconstitution inflammatory syndrome. Clin Infect Dis. 2008 Feb 15;46(4):e38-40.

  17. Sungkanuparph S, Vibhgool A, Mootsikapun P, Chetchotisakd P, Tansupjhaswaswadikul S, Bowonwatanuwong C. Opportunistic infections alter the initiation of highly active antiretroviral therapy in advanced AIDS patients in an area with a high prevalence of tuberculosis. AIDS. 2003;17:2129-31.

  18. Lederman M, Valdez H. Inmune restoration with antiretroviral therapies: implications for clinical management. JAMA. 2000;284:223-28.

  19. French M, Price P, Stone S. Immune restoration disease after antiretroviral therapy. AIDS. 2004 Aug 20;18(12):1615-27.

  20. Cheng V, Yuen K, Chan W, Wong S, Ma E, Chan R. Immunorestitution disease involving the innate and adaptive response. Clin Infect Dis. 2000 Jun;30(6):882- 92.

  21. Aberg JA. Reconstitution of immunity against opportunistic infections in the era of potent antiretroviral therapy. . AIDS Clin Rev. 2000-2001:115-38

  22. Rennert W, Kilner D, Hale M, Stevens G, Stevens W, Crewe-Brown H. Tuberculosis in children dying with HIV-related lung disease: clinical-pathological correlations. Int J TubercLungDis. 2002 Sep;6(9):806-13.

  23. Martínez García R. Lactato deshidrogenasa (LDH) y morbilidades asociadas a inmunocompromiso por VIH/sida. (Tesis de Maestría de Infectologia y Enfermedades Tropicales). La Habana: IPK; 2006.

  24. Morrow BM, Samuel CM, Zampoli M, Whitelaw A, Zar HJ. Pneumocystis pneumonia in South African children diagnosed by molecular methods. BMC Res Notes. 2014;7:26.

  25. Sterling T, Chaisson R. General clinical manifestations of human immunodeficiency virus infection (including the acute retroviral syndrome and oral, cutaneous, renal, ocular, metabolic, and cardiac diseases). In: Mandell GL BJ, Dolin R, eds. Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Elsevier Churchill Livingstone; 2009.

  26. Tun N, London N, Kyaw MK, Smithuis F, Ford N, Margolis T, et al. CMV retinitis screening and treatment in a resource-poor setting: three-year experience from a primary care HIV/AIDS programme in Myanmar. J Int AIDS Soc. 2011;14:41.

  27. Pérez Mato S, Van Dyke R. Pulmonary infections in children with HIV infection. Semin Respir Infect. 2002 Mar;17(1):33-46.

  28. Cascio A, Iara C, Ruggeri P, Fries W. Cytomegalovirus pneumonia in patients with inflammatory bowel disease: a systematic review. Int J Infect Dis. 2012;16:e474–e9.

  29. Xiao J, Gao G, Li Y, Zhang W, Tian Y, Huang Y, et al. Spectrums of Opportunistic Infections and Malignancies in HIV-Infected Patients in Tertiary Care Hospital, China. PLoS One. 2013 Oct 25;8(10):e75915. doi: 10.1371/journal.pone.0075915.

  30. d'Arminio Monforte A, Vago L, Lazzarin A, Boldorini R, Bini T, Guzzetti S, et al. AIDS-defining diseases in 250 HIV-infected patients; a comparative study of clinical and autopsy diagnoses. AIDS. 1992 Oct;6(10):1159-64.

  31. Rivero A, Pulido F, Cayla J, Iribarren JA, Miro JM, Moreno S, et al. The Spanish AIDS Study Group and Spanish National AIDS Plan (GESIDA/Secretaria del Plan Nacional sobre el Sida) recommendations for the treatment of tuberculosis in HIVinfected individuals. Enferm. Infecc. Microbiol. Clin. 2013; 31: 672-684. FI: 1.478 (Q4).

  32. Menon LR, Divate S, Acharya VN, Mahashur AA, Natrajan G, Almeida AF. Utility of bronchoalveolar lavage in the diagnosis of pulmonary infections in immunosuppressed patients. J Assoc Physicians India. 2002 Sep;50:1110-4.

  33. Drew WL. Cytomegalovirus. In: Goldman L, Schafer AI, eds. Goldman´s Cecil Medicine. 24th ed. Philadelphia: Saunders Elsevier; 2011.

  34. Crothers K, Thompson B, Burkhardt K, Morris A, Flores S, Diaz P, et al. HIVAssociated Lung Infections and Complications in the Era of Combination Antiretroviral Therapy. Proc Am Thorac Soc. 2011 Jun 1;8(3):275–81.

  35. Carrillo Esper R. Citomegalovirus reactivation in critical ill intensive care patients. Gac Med Mex. 2011 Mar-Apr;147(2):159-62.

  36. Menéndez Capote R. Caracterización clínica de pacientes adultos angolanos con VIH/sida: Contribución a la lucha contra el SIDA en África. Luanda [Tesis para optar por el grado de Doctor en Ciencias]. La Habana: IPK; 2008.

  37. Bartlett J, Gallart M. Medical Management of HIV Infection, 2005-2006 Baltimore Maryland: The Johns Hopkins University; 2006. p. 346-7.

  38. Kim T, Mi Moon S, Sung H, Kim M, Kim S, Choi S, et al. Outcomes of non-HIVinfected patients with Pneumocystis pneumonia and concomitant pulmonary cytomegalovirus infection. Scand J of Infect Dis. 2012 Sep;44(9):670-7. doi: 10.3109/00365548.2011.652665.

  39. Ushiki A, Yamazaki Y, Hama M, Yasuo M, Hanaoka M, Kubo K. Viral infections in patients with an acute exacerbation of idiopathic interstitial pneumonia. Respir Investig. 2014 Jan;52(1):65-70.

  40. Goussard P, Kling S, Gie R, Nel E, Heyns L, Rossouw G, et al. CMV Pneumonia in HIV-Infected Ventilated Infants. Pediatr Pulm. 2010 Jul;45:650-5.

  41. Parkhomenko I, Tishkevich O, Shagil'dian V, Solnyshkova T, Nikonova E. Pathomorphogenesis of cytomegalovirus lungs lesions in HIV infection. Arkh Patol. 2004 Jul-Aug;66(4):20-3.

  42. Santos GC, Parra ER, Stegun FW, Cirqueira CS, Capelozzi VL. Immunohistochemical detection of virus through its nuclear cytopathic effect in idiopathic interstitial pneumonia other than acute exacerbation. Braz J Med Biol Res. 2013 Nov;46(11):985-92.

  43. Perfect JR, Casadevall A. Cryptococcosis. Infect Dis Clin North Am. 2008;16:837-74.

  44. Meya D, Manabe Y, Castelnuovo B, Cook B, Elbireer A, Kambugu A, et al. Costeffectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings. Clin Infect Dis. 2010;51(4):448-55.

  45. Noda Albelo AL, Vidal Tallet LA, Pérez Lastre JE, Villafranca RE. Interpretación clínica del conteo de linfocitos T CD4 positivos en la infección por VIH. Rev Cubana Med. 2013 Jun;52(2):118-27.

  46. Reina J, Weber I, Riera E, Busquets M, Morales C. Usefulness of a real-time quantitative polymerase-chain reaction (PCR) assay for the diagnosis of congenital and postnatal cytomegalovirus infection. An Pediatr (Barc). 2014 May;80(5):299- 303. doi: 10.1016/j.anpedi.2013.06.036

  47. Corona-Nakamura AL, Arias-Merino MJ. Management of CMV-Associated Diseases in Immunocompromised Patients. In: Price P, Makwana N, Brunt S, eds. Manifestations of Cytomegalovirus Infection. InTech; 2013. DOI: 10.5772/56141. (Citado Enero 25, 2014). Available from: http://www.intechopen.com/books/manifestations-of-cytomegalovirusinfection/ management-of-cmv-associated-diseases-in-immunocompromisedpatients

  48. Rodríguez-Barradas M, Stool E, Musher D, Gathe JJ, Goldstein J, Genta R, et al. Diagnosting and treating cytomegalovirus pneumonia in patients with AIDS. Clin Infect Dis. 1996 Jul;23(1):76-81.

  49. Bégaud E, Feindirongal G, Versmisse P, Ipero J, Léal Germani Y, Morvan J, et al. Broad spectrum of correceptor usage and rapad disease progresión in HIV-1- Infected individuals from Central African Republic. AIDS Res Hum Retroviruses. 2003;19:551-60.




2020     |     www.medigraphic.com